Virpax Pharmaceuticals

Virpax Pharmaceuticals Set for Transformative Year with High Hopes for Non-Addictive Pain Management Solutions

BERWYN, PA — Recent developments have been flourishing for Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX). The Pennsylvania-based pharmaceutical innovator recently unveiled its financial records for 2023 and shared a series of …

Virpax Pharmaceuticals Set for Transformative Year with High Hopes for Non-Addictive Pain Management Solutions Read More
Frontage Laboratories

EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan’s Drug Development Hurdles

EXTON, PA — In a strategic move poised to reshape the pharmaceutical landscape, Japan’s EPNextS Group and US-based Frontage Laboratories, Inc. have announced a partnership aimed squarely at overcoming Japan’s …

EPNextS Group and Frontage Laboratories Forge Alliance to Tackle Japan’s Drug Development Hurdles Read More


Nordic Pharma

Nordic Pharma Welcomes Esteemed Oculoplastic Surgeon to Medical Advisory Board Ahead of Dry Eye Therapy Launch

BERWYN, PA — Nordic Pharma, Inc., a subsidiary of the international healthcare company Nordic Group B.V., has announced the latest addition to its U.S. Medical Advisory Board (MAB)—John P. Fezza, …

Nordic Pharma Welcomes Esteemed Oculoplastic Surgeon to Medical Advisory Board Ahead of Dry Eye Therapy Launch Read More

Provell Pharmaceuticals

The Revolution in Drug Pricing: Provell Pharmaceuticals and Cost Plus Drugs Forge New Pathway for Affordable Medication

HONEY BROOK, PA — Provell Pharmaceuticals recently announced a partnership with Mark Cuban’s brainchild Cost Plus Drug Company, PBC (Cost Plus Drugs). They are set on bringing life-saving drugs to …

The Revolution in Drug Pricing: Provell Pharmaceuticals and Cost Plus Drugs Forge New Pathway for Affordable Medication Read More
Windtree Therapeutics

Windtree Therapeutics Strikes Landmark Deal with Lee’s Pharmaceutical for Heart Failure Treatments

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a significant license agreement with Lee’s Pharmaceutical (HK) Limited (“Lee’s”), a leading Hong Kong-based pharmaceutical company. The deal involves the …

Windtree Therapeutics Strikes Landmark Deal with Lee’s Pharmaceutical for Heart Failure Treatments Read More